Although these 7 months of improvement did not reach statistical significance, participation in clinical trials and the number of biological agents received were strong predictors of survival in these platinum-resistant patients.
← all excerpts
The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients.
1
—
—